Drugs / MCT
last change Mar 2025 re-read 9 days ago

MCT

Developed for
asthma
Investigated by
National Heart, Lung, and Blood Institute (NHLBI) · University of North Carolina, Chapel Hill

Trials 1

2020202120222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT04129931 Dec 2019 → Feb 2025 asthma University of North Carolina, Chapel Hill Completed Missed primary

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as MCT ClinicalTrials.gov intervention name — accepted as the source's own label NCT04129931 ↗